Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy.

CONCLUSION: Predictive and prognostic values of clinicopathological features, like pCR and sTIL, differ depending on the evaluated molecular subtype.
PMID: 29651385 [PubMed]

Source: Clinical Breast Cancer - April 10, 2018 Category: Cancer & Oncology Authors: Galvez M, Castaneda CA, Sanchez J, Castillo M, Rebaza LP, Calderon G, Cruz M, Cotrina JM, Abugattas J, Dunstan J, Guerra H, Mejia O, Gomez HL Tags: World J Clin Oncol Source Type: research